Acute Respiratory Distress Syndrome (ARDS) Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the acute respiratory distress syndrome (ards) market grown in recent years?
There has been a swift expansion of the acute respiratory distress syndrome (ARDS) market size in the past few years. The market, which is set to surge from $1.29 billion in 2024 to $1.42 billion in 2025, will do so with a compound annual growth rate (CAGR) of 10.4%. Factors such as progress in critical care medicine, an increase in the elderly population, enhancements in pulmonary rehabilitation, and the formation of multidisciplinary care teams have contributed to the growth experienced during the historic period.
How is the acute respiratory distress syndrome (ards) market size expected to evolve during the forecast period?
In the ensuing years, the market size for acute respiratory distress syndrome (ARDS) is predicted to witness swift expansion. By 2029, it is anticipated to reach a value of $2.17 billion, growing at a compound annual growth rate (CAGR) of 11.1%. The surge in growth during the forecast period can be credited to the worldwide readiness for healthcare, the progress in vaccine creation and managing infectious diseases, the use of telemedicine and remote monitoring, and the adoption of patient-focused care models. Notable trends projected for the forecast duration encompass artificial lung devices, tailored ventilation strategies, lung protective ventilation, and medicinal treatments for various ards subtypes.
Get your acute respiratory distress syndrome (ards) market report here!
Which key drivers are propelling the acute respiratory distress syndrome (ards) market’s growth?
The escalating cases of pneumonia could likely spur the acute respiratory distress syndrome (ARDS) market’s expansion. Pneumonia, a lung infection that leads to fluid or pus accumulation in the lungs’ air sacs, or alveoli, generates an inflammatory response in the lungs. This reaction further heightens the permeability of the blood vessels and facilitates fluid seepage into the alveoli. The resultant fluid build-up obstructs the exchange of oxygen and carbon dioxide, inducing breathing difficulties. As elucidated by the Centre for Tropical Medicine and Global Health, a healthcare research leader based in the UK, in November 2023, there was a substantial surge in pneumonia cases in Kenya, with the count reaching 793,864 in 2022-2023 from 477,186 cases in 2020-2021. Consequently, this surge in pneumonia prevalence fosters the ARDS market’s growth. Emerging Acute Respiratory Distress Syndrome (ARDS) Market Driver: The Surge in Respiratory Diseases May Bolster the Progress of The Acute Respiratory Distress Syndrome (ARDS) Market
What are the market segments in the acute respiratory distress syndrome (ards) industry?
The acute respiratory distress syndrome (ARDS) market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
3) By Severity: Mild, Moderate, Severe
4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
Subsegments:
1) By Diagnosis: Imaging Tests, Blood Tests, Lung Function Tests, Other Diagnostic Methods
2) By Treatment: Mechanical Ventilation, Medications, Extracorporeal Membrane Oxygenation (ECMO), Supportive Care, Other Treatment Options
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
Which leading companies are shaping the growth of the acute respiratory distress syndrome (ards) market?
Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, ResMed Inc., Smiths Medical Inc., Dräger Safety AG & Co. KGaA., Getinge AB, Mallinckrodt PLC, Masimo Corporation, United Therapeutics Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Zuventus Healthcare Ltd., Windtree Therapeutics Inc., Faron Pharmaceuticals Oy, AcelRx Pharmaceuticals Inc.
What key trends are currently impacting the acute respiratory distress syndrome (ards) market’s development?
Leading businesses in the acute respiratory distress syndrome (ARDS) market are concentrating their efforts on creating novel drugs and supplements like Aviptadil, HSP90 inhibitors among other items in order to retain their market position. Aviptadil, being a manufactured vasoactive intestinal peptide (VIP), specifically binds to receptors found on lung alveolar type II cells. For example, in November 2022, Zuventus Healthcare Ltd., a pharmaceutical manufacturer based in India, introduced Aviptadil to treat ARDS. An example of a vasoactive intestinal peptide supplement, Aviptadil significantly enhances breathing and reduces mortality in patients with ARDS. The mechanism behind this is the ability of Aviptadil’s to safeguard and rejuvenate Type-2 Pneumocytes, revitalize Type-1 Pneumocytes, promote surfactant synthesis and diminish IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13005
Which geographic areas are influencing the growth of the acute respiratory distress syndrome (ards) market?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024. The regions covered in acute respiratory distress syndrome (ARDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024
Respiratory Monitoring Devices Global Market Report 2024
Anesthesia And Respiratory Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
